Carregant...
Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) is a devastating hypoxemic respiratory failure, characterized by disruption of the alveolar-capillary membrane barrier. Current management for ARDS remains supportive, including lung-protective ventilation and a conservative fluid strategy. Mesenchymal stem...
Guardat en:
| Publicat a: | Stem Cell Res Ther |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6915956/ https://ncbi.nlm.nih.gov/pubmed/31843004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-019-1518-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|